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Hypotonicity Induces TRPV4-Mediated
Nociception in Rat
seems tightly regulated by intracellular and extracellular
calcium concentration (Strotmann et al., 2003; Wata-
nabe et al., 2003).
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Xiaojie Chen, David B. Reichling,
and Jon D. Levine* Recent studies suggest that, like TRPV1, TRPV4 may
be a polymodal receptor, since TRPV4 can be activatedDivision of Neuroscience
University of California, San Francisco by heat (Guler et al., 2002; Watanabe et al., 2002b), low
pH, and citrate (Suzuki et al., 2003) in addition to osmoticSan Francisco, California 94143
stimulation. TRPV4 is also activated by phorbol ester
derivative 4-PDD, which does not activate protein ki-
nase C, suggesting the existence of an endogenous lipidSummary
ligand (Watanabe et al., 2002a).
Although literature reports describe the presence ofWe hypothesized that TRPV4, a member of the tran-
sient receptor family of ion channels, functions as a TRPV4 mRNA in sensory neurons (Liedtke et al., 2000;
Guler et al., 2002), most studies on TRPV4 activationsensory transducer for osmotic stimulus-induced no-
ciception. We found that, as expected for a transducer and function have been performed in transfected cells
or cell lines expressing TRPV4 (Liedtke et al., 2000; Strot-molecule, TRPV4 protein is transported in sensory
nerve distally toward the peripheral nerve endings. In mann et al., 2000; Wissenbach et al., 2000; Nilius et al.,
2001; Voets et al., 2002; Watanabe et al., 2002a, 2002b).vivo single-fiber recordings in rat showed that hypo-
tonic solution activated 54% of C-fibers, an effect en- Watanabe et al. (2002b) showed the existence of an
endogenous current in aortic endothelial cells with func-hanced by the hyperalgesic inflammatory mediator
prostaglandin E2. This osmotransduction causes noci- tional hallmarks of TRPV4, and they proposed TRPV4
to be a temperature-sensing channel in native endothe-ception, since administration of a small osmotic stimu-
lus into skin sensitized by PGE2 produced pain-related lium. Recently, Suzuki et al. (2003) showed impaired acid
and pressure sensation in mice lacking TRPV4, whereasbehavior. Antisense-induced decrease in expression
of TRPV4 confirmed that the channel is required for hot and touch sensation was unaffected. TRPV4 has been
detected in sensory tissues such as cochlear hair cells,hypotonic stimulus-induced nociception. Thus, we
conclude that TRPV4 can function as an osmo-trans- vibrissal Merkel cells, and sensory ganglia (Liedtke et
al., 2000; Guler et al., 2002), but Suzuki et al. (2003) wereducer in primary afferent nociceptive nerve fibers. Be-
cause this action is enhanced by an inflammatory me- the first to report a contribution of TRPV4 to sensory
function.diator, TRPV4 may be important in pathological states
and may be an attractive pharmacological target for In the present study, we addressed the physiological
role of TRPV4 in rat primary afferent neurons and specifi-the development of novel analgesics.
cally asked whether TRPV4 is involved in the detection
of osmolarity in nociceptors and whether osmotrans-Introduction
duction results in nociception.
Members of the transient receptor potential (TRP) family,
such as the vanilloid receptor TRPV1 (Caterina et al., Results
1997), the vanilloid receptor-like protein TRPV2 (Ca-
terina et al., 1999), and the TRPM8 receptor (Peier et Hypotonicity Depolarizes Nociceptive
al., 2002), are expressed in mammalian sensory neurons DRG Neurons
and are thought to function as transducers for thermal To investigate the effect of hypotonic challenge on the
and chemical stimuli. Recently, the expression of a new membrane potential of cultured dorsal root ganglion
TRP family member TRPV4 (Liedtke et al., 2000; Strot- (DRG) neurons, current clamp recordings were per-
mann et al., 2000; Wissenbach et al., 2000; Delany et formed. In isotonic solution (312 mOsm), DRG neurons
al., 2001) was also detected by in situ hybridization in did not spontaneously fire action potentials. The perfu-
trigeminal ganglion neurons (Liedtke et al., 2000) and sion of a 30% hypotonic solution (219 mOsm) induced
by Northern blot analysis in dorsal root ganglia (Guler a depolarization of the membrane in some neurons with-
et al., 2002). out eliciting any action potentials (data not shown). We
TRPV4 is a nonselective cation channel, first de- then investigated the effect of a hypotonic challenge
scribed as an osmosensor, activated by a decrease in when neurons were already stimulated by two different
osmolarity of as little as 30 mOsm (Liedtke et al., 2000; electrical protocols: a long depolarizing pulse (1 s/100
Strotmann et al., 2000). The opening of the TRPV4 chan- pA) or a combination of a hyperpolarizing (500 ms/100
nel by a hypotonic stimulus does not appear to depend pA) followed by a depolarizing (500 ms/100 pA) current
on direct mechanotransduction since it is not affected pulse. Under those conditions, perfusion of a 30% hypo-
by membrane stretching (Strotmann et al., 2000). Rather, tonic solution elicited firing of multiple action potentials
it seems to result from Src family tyrosine kinase-depen- in 32% of neurons (11 of 34; Figure 1A). As shown in
dent phosphorylation (Xu et al., 2003). TRPV4 gating Figure 1B, in responsive neurons, perfusion of hypotonic
solution led to membrane depolarization (from 54  4
to 40  5 mV, n  11, p  0.05) while in nonresponsive*Correspondence: levine@itsa.ucsf.edu
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Figure 1. Hypotonic Solution Excites Neurons Expressing TRPV4
(A) Current clamp recording of DRG neurons. A short depolarizing (10 ms/100 pA) stimulus was used in isotonic solution (312 mOsm) to
characterize the action potential waveform of each neuron. Two current stimulation protocols were applied to DRG neurons: a long depolarization
(1 s/100 pA) and a depolarization (500 ms/100 pA) following a prehyperpolarizing current (500 ms/100 pA). The response to the two stimulation
protocols were recorded under isotonic, 30% hypotonic (219 mOsm), and after return to isotonic solution.
(B) Mean  SEM of the membrane potential value of sensitive (n  11) or insensitive (n  23) neurons in isotonic (white bars) and in 30%
hypotonic (black bars) conditions.
(C) A cell responsive to the hypotonic challenge expressed TRPV4 mRNA (cell 1), whereas a nonresponsive cell (cell 2) did not.
neurons, the membrane potential remained unchanged In 31 neurons, immediately after electrophysiological
recordings, the cytoplasm was harvested and single-(54  5 to 53  5 mV, n  23). Cells that fired became
quiescent a few seconds after replacing the bath with cell RT-PCR analysis was performed. TRPV4 mRNA was
expressed in the 11 neurons that fired action potentialsisotonic solution, and over a couple of minutes, the
membrane potential returned to baseline. in response to an electrical depolarization during a 30%
Osmosensing by DRG Neurons
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hypotonic stimulus, whereas the mRNA was undetect- 30% hypotonic stimulus. Another set of nociceptors was
tested with three increasing levels of hypotonicity (15%,able in the 20 neurons that did not fire action potentials
(Figure 1C). 30%, and 40%), and in those cells the mean response
to hypotonic stimulus also increased progressively withTwo types of DRG neurons have been described
based on the shape of the falling phase of the action degree of hypotonicity (Figure 2D). Following calcium
imaging, the cytoplasm of 13 cells responsive to anpotential (Gorke and Pierau, 1980; Harper and Lawson,
1985). Nociceptive DRG neurons usually have a long- increasing level of hypotonic stimulus (15% and 30%)
was harvested and RT-PCR was performed. As shownduration action potential with a shoulder on the falling
phase of the action potential (Figure 1A), whereas non- in Figure 2C (inset), TRPV4 expression was detectable
in most (11/13) of the responding cells.nociceptive neurons have a shorter duration monopha-
sic action potential. A short depolarizing (10 ms/100 pA)
stimulus was used in isotonic solution to characterize Increase in [Ca2]i Depends
the action potential waveform (Figure 1A) of each neuron on Extracellular Calcium
recorded. In 9 of 11 neurons responsive to hypotonic Presence of calcium in the extracellular solution is es-
stimuli, a shoulder occurred on the falling phase of the sential for the hypotonic stimulus-induced increase in
action potential, strongly suggesting that TRPV4 is in- [Ca2]i via TRPV4 (Strotmann et al., 2000; Nilius et al.,
volved in the response of nociceptors to hypotonicity. 2003). To confirm that an extracellular influx of Ca2
ions is involved in the hypotonicity-induced response
of nociceptors, we challenged nociceptors with a 30%Hypotonic Stimulus Increases Intracellular Ca2
in Nociceptors hypotonic solution, perfused them with iso-osmotic
Ca2-free solution for 3 min, and then challenged themCalcium ions appear to play an integral role in TRPV4-
mediated responses to hypotonicity (Liedtke et al., 2000; with a 30% hypotonic Ca2-free solution. None of the
hypotonic-responsive neurons showed an increase inStrotmann et al., 2000; Wissenbach et al., 2000; Nilius
et al., 2001). Using ratiometric calcium imaging, 35% [Ca2]i when challenged with a hypotonic Ca2-free solu-
tion (data not shown, n  10). We then challenged 28of neurons tested (102/288) showed an increase in the
intracellular concentration of free calcium ions ([Ca2]i). neurons by perfusing a 30% hypotonic solution (219
mOsm). When the [Ca2]i increase reached a plateau,As seen in Figure 2A, while 45% of small- to medium-
sized neurons (diameter less than 40 m) were respon- the solution was switched to Ca2-free 30% hypotonic
solution (218 mOsm). Switching to a Ca2-free hypotonicsive to a 30% hypotonic stimulus, only 17% of large
neurons (diameter 41 to 80 m) were responsive. This solution induced an immediate decrease in [Ca2]i (Fig-
ures 3A and 3B). Thus, the initiation, as well as thefinding is consistent with responding cells being noci-
ceptors, and we narrowed our subsequent studies of plateau, of the hypotonic stimulus-induced [Ca2]i in-
crease in nociceptors depends on entry of extracellularthe hypotonicity-induced increase in [Ca2]i to neurons
with diameters less than 40 m. Ca2, probably through TRPV4 channels.
To confirm that nociceptors respond to hypotonic
stimulation, we determined whether the neurons that Extracellular Ca2 Influx Triggers Mobilization
respond to hypotonic stimuli were capsaicin sensitive. from Intracellular Calcium Stores
Following hypotonic challenge, after [Ca2]i had recov- To test if intracellular calcium stores contribute to the
ered to control level, capsaicin (1 M) was perfused hypotonicity-induced increase in [Ca2]i, neurons were
for 10 s. As shown in Figure 2B, 77% (96/126) of DRG preincubated with different blockers for 20 min: SKF
neurons, with a diameter less than 40 m, responsive 96365 (20 M, ryanodine receptor blocker), or SKF
to hypotonicity were also capsaicin sensitive. Since our 96365 (20M) thapsigargin (4M, Ca2-ATPase inhib-
goal was to characterize TRPV4 function in nociceptors, itor), or SKF 96365 (20M)CPA (20M, cyclopiazonic
the remainder of our studies focused on those capsa- acid, endoplasmic reticulum calcium pumps blocker).
icin-sensitive neurons with diameters less than 40 m. After the preincubation, neurons were challenged with
a hypotonic solution also containing the blockers. To
measure the response, we averaged the value of theHypotonicity-Induced Increase in [Ca2]i Depends
on Stimulus Intensity fluorescence ratio when the hypotonicity-induced in-
crease in [Ca2]i reaches a plateau. In parallel to theIn transfected cells, TRPV4 can be activated by a de-
crease in tonicity as small as 30 mOsm, and the hypoto- cells incubated with the blockers, control cells were
recorded the same day in the same conditions but with-nicity-induced increase in [Ca2]i depends on the degree
of hypotonicity (Liedtke et al., 2000; Strotmann et al., out intracellular store blockers. The fluorescence ratio
at the plateau was then normalized (fluorescence ratio2000). We investigated whether TRPV4 had similar prop-
erties in nociceptors. We challenged 86 neurons with a during 30% hypotonic/fluorescence ratio during iso-
tonic) and reported in Figure 3C. The intracellular store15% hypotonic solution (265 mOsm) for 2 min followed
by a 30% hypotonic solution (219 mOsm). Increasing blockers did not prevent the hypotonic-induced [Ca2]i
increase or diminish the number of cells responding tothe hypotonicity increased the number of cells responding
to hypotonic stimulus, as well as the magnitude of the the stimulus, but the hypotonicity-induced increase in
[Ca2]i consistently reached a lower fluorescence ratioresponse in individual cells (Figure 2C). When chal-
lenged with the 15% hypotonic solution, 27 of 86 neu- in presence of blockers. The normalized fluorescence
ratio in control cells was 1.17 0.02 (n 60) in hypotonicrons showed a small increase in [Ca2]i (normalized fluo-
rescence ratio, 1.09  0.02, n  11) and 34 neurons solution, whereas in neurons preincubated with block-
ers, the ratio was 1.07  0.01 (n  16) for hypotonic showed a larger increase (1.19  0.03, n  11) with the
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Figure 2. Hypotonicity Increases [Ca2]i
(A) Diameter distribution of neurons sensitive to a 30% hypotonic stimulus.
(B) Diameter distribution of hypotonic and capsaicin-responsive neurons.
(C) Example of a cell responding gradually to two degrees of hypotonicity (15% and 30%). This cell expressed mTRPV4, and the housekeeping
gene GAPDH was chosen as a positive control.
(D) Peak increase in [Ca2]i (mean  SEM) obtained for neurons stimulated by three degrees of hypotonicity (15%, 30%, and 40%). Only
neurons responding to the three hypotonic concentrations were included in the graph (n  10). Data are expressed as the fluorescence ratio
amplitude of the effect of hypotonic stimulation, normalized to the fluorescence ratio obtained in isotonic solution (312 mOsm).
SKF 96365, 1.07  0.02 (n  8) for hypotonic  SKF Blockers of TRPV4 Attenuate the Hypotonic
Stimulus-Induced [Ca2]i Increase96365  thapsigargin, and 1.07  0.02 (n  7) for
hypotonic  SKF 96365  CPA (Figure 3C). The de- in Nociceptors
Lanthanum (La3) and ruthenium red (RR) are knowncrease in the hypotonicity-induced increase in [Ca2]i
was statistically significant in presence of SKF 96365 to reduce TRPV4-mediated response (Strotmann et al.,
2000; Watanabe et al., 2002a). We tested each agent onversus the control cells (p  0.05, unpaired Student’s t
test), and adding thapsigargin or CPA did not induce stably transfected CHO-TRPV4 and CHO-MOCK cells
in order to calibrate their effect on TRPV4-mediatedfurther decrease. We conclude that intracellular stores
were not essential for the response to hypotonicity in [Ca2]i increases in nociceptors. The CHO-TRPV4 cells
showed a 2.5-fold increase in the fluorescence rationociceptors but may play a role in amplification of the
response. during a 30% hypotonic stimulus (mean  SEM of the
Osmosensing by DRG Neurons
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Figure 3. Extracellular Calcium Contributes to the Hypotonicity-Induced Increase in [Ca2]i
(A) Response of a DRG neuron as the 30% hypotonic solution (215 mOsm) was switched to a 30% hypotonic solution Ca2-free (hypoCa0)
when the hypotonicity-induced increase in [Ca2]i reaches a plateau.
(B) Mean  SEM of the mean of normalized fluorescence ratio when neurons are challenged with the protocol shown in (A), n  28.
(C) Mean of normalized fluorescence ratio  SEM for DRG stimulated by various extracellular solutions (n  8 for each condition). Cells were
preincubated for 20 min in isotonic solution (control cells) or isotonic containing either SKF 96365 (20 M), or SKF 96365 (20 M) thapsigargin
(4 M), or SKF 96365 (20 M)  CPA (20 M). After preincubation, cells were challenged during 3 min with either 30% hypotonic, or 30%
hypotonic  SKF 96365 (20 M), or a 30% hypotonic solution  SKF96365 (20 M)  thapsigargin (4 M), or a 30% hypotonic solution 
SKF 96365 (20 M)  CPA (20 M).
fluorescence ratio was 0.56 0.01 in isotonic and 1.41 confounding desensitization and the blocking effect of
the drugs tested, we challenged the cells with a 30%0.05 in hypotonic solution; n  40), while the control
CHO-MOCK cells did not show any increase (the fluores- hypotonic stimulus; when the hypotonic-induced [Ca2]i
increase reached a plateau, the perfusion was switchedcence ratio was 0.32  0.01 in isotonic and 0.33  0.01
in hypotonic solution; n  55). to a hypotonic solution containing either La3 (1 M) or
RR (10 M).We observed tachyphylaxis upon consecutive hypo-
tonic stimulation (data not shown). Therefore, to avoid Perfusion of La3 (1 M) on CHO-TRPV4 cells induced
Neuron
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Figure 4. Effect of TRPV4 Blockers and 4-PDD on the Hypotonic-Induced [Ca2]i Increase
(A) Effect of the perfusion of La3 (1 M) and RR (10 M) on hypotonic-induced [Ca2]i increase in CHO-TRPV4 cells (n  10).
(B) La3 blocked 45% (n  5) and RR blocked 70% (n  4) of the hypotonic-induced increase in [Ca2]i in nociceptors.
(C) Example of a CHO-TRPV4 response to an isotonic solution  4-PDD (10 M). Insert: mean  SEM of the increase of the fluorescence
ratio when CHO-TRPV4 cells are challenged with a 30% hypotonic solution or an isotonic solution  4-PDD (10 M), n  10.
(D) Mean  SEM of the normalized fluorescence ratio for different extracellular solutions. For the left part of the graph n  9, for the middle
part n  24, and for the right part n  6. For all graphs, results are expressed as the mean  SEM of the normalized fluorescence ratio.
a 45% reduction of the hypotonic-induced increase in in nociceptors was inhibited by 45% during the perfu-
sion of La3 (Figure 4B, p 0.05, paired Student’s t test,[Ca2]i (Figure 4A, p  0.05, paired Student’s t test; n 
10). RR (10 M) blocked 60% of the hypotonic-induced n  5) and by 70% during the perfusion of RR (Figure
4B, p 0.05, paired Student’s t test, n 4). These resultsincrease of [Ca2]i in CHO-TRPV4 cells (Figure 4A, p 
0.05, paired Student’s t test, n  9). As seen in Figure support the involvement of TRPV4 in nociceptor osmo-
sensitivity.4B, the hypotonic stimulus-induced increase in [Ca2]i
Osmosensing by DRG Neurons
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4-PDD Causes an Increase in [Ca2]i
in Nociceptors
The phorbol ester 4-PDD (4-phorbol 12,13-dideca-
noate), an analog of phorbol 12-myristate 13-acetate
(PMA) that does not activate protein kinase C, is re-
ported to be an agonist of TRPV4 (Watanabe et al.,
2002a). As shown previously, perfusion of 4-PDD (10
M) on CHO-TRPV4 cells was more efficacious than a
30% hypotonic stimulus (Watanabe et al., 2002a). As
shown in Figure 4C, the mean fluorescence ratio during
hypotonic stimulation was 1.35  0.03 versus 2.7 
0.3 during the perfusion of isotonic solution containing
4-PDD (10 M, p  0.05, paired Student’s t test, n 
10). DRG neurons (diameters 40 m) were challenged
with a 30% hypotonic solution for 3 min, rinsed for 3 min,
Figure 5. TRPV4 Protein Is Detected in Saphenous Nervesand then challenged with an isotonic solution containing
Western blot analysis shows two protein bands at the predicted4-PDD (10 M) for 3 min. Of 77 neurons tested, 33
molecular weight (98 kDa to 107 kDa) for TRPV4 protein in the(42%) were responsive to hypotonic stimulation, with
saphenous nerve and CHO-TRPV4 cells. CHO-MOCK cells and skel-51% of those neurons (17/33) sensitive to both the 30%
etal muscle did not present any band. To obtain similar levels ofhypotonic and 4-PDD stimuli. We suggest that neurons the TRPV4 protein expression on the gel, only 4 g/lane of total
responsive to both stimuli are likely to express TRPV4. protein were loaded for CHO-TRPV4 and CHO-MOCK, whereas 16
We focused further on the nociceptors (capsaicin- g/lane were loaded for the saphenous nerve and skeletal muscle.
responsive neurons with a diameter 40 m) that re-
sponded to both stimuli. As shown in Figure 4D, unlike in
transfected cells, the magnitude of the 4-PDD-induced synthetic peptide corresponding to the C terminus of
increase in [Ca2]i in nociceptors was not significantly rat TRPV4, the same epitope used by others (Delany et
different from that induced by the hypotonic stimulus al., 2001; Guler et al., 2002). The specificity of the anti-
(p  0.05, paired Student’s t test, n  9). body was confirmed by testing it in non-TRPV4-express-
Watanabe et al. (2002a) showed in TRPV4-transfected ing tissues and cells, including skeletal muscle and
cells that 4-PDD potentiated the hypotonic-induced CHO-MOCK cells, using Western blot, immunochemis-
increase in [Ca2]i. To investigate this potential effect try, and flow cytometry (data not shown). Using this
on nociceptors, neurons were first perfused with a 30% antibody, TRPV4 protein could not be detected in DRG
hypotonic solution and when the [Ca2]i increase reached (Guler et al., 2002). Therefore, we performed further ex-
a plateau, the perfusion was switched to hypotonic  periments in which the saphenous nerve was ligated to
4-PDD (10 M). As shown in Figure 4D, addition of dam transport of proteins from the cell body toward
4-PDD did not significantly modify the hypotonic- the periphery (Parada et al., 2003). A 5 mm section of
induced increase in the [Ca2]i (p  0.05, paired Stu- saphenous nerve, proximal to the ligature, was removed
dent’s t test, n  24). 3 days after ligation, and Western blot analysis was
In TRPV4-transfected cells, increasing the level of in- performed on the tissue to visualize TRPV4 protein. As
tracellular calcium was reported to inhibit TRPV4 activa- shown in Figure 5, TRPV4 protein was detected in the
tion by 4-PDD (Watanabe et al., 2002a). To investigate saphenous nerve segment. As reported previously in
if it was also the case in nociceptors, blockers of intracel- TRPV4-transfected cells (Xu et al., 2003), a doublet be-
lular stores were used. Nociceptors were preincubated tween 98 and 107 kDa was detected, suggesting varying
for 20 min with CPA (20 M)  SKF 96365 (20 M), degrees of glycosylation of the TRPV4 protein. These
challenged with a 30% hypotonic  CPA  SKF 96365, findings demonstrate that TRPV4 is present in sensory
and when the [Ca2]i increase reached a plateau, nerve fibers, presumably being transported toward the
4-PDD (10 M) was added. As shown in Figure 4D, in peripheral nerve endings.
the presence of intracellular blockers, addition of
4-PDD to a hypotonic stimulus induced a significant Primary Afferent Nerve Fibers Respond
increase in the fluorescence ratio (normalized fluores- to Hypotonic Stimulus and This Response
cence ratio was 1.07  0.02 before 4-PDD and 1.23  Is Enhanced by PGE2
0.05 after 4-PDD, p 0.05, paired Student’s t test, n Because TRPV4 protein appears to be transported to
6). The 4-PDD-induced potentiation was blocked by peripheral nerve endings, we tested if we could elicit
subsequent application of RR (10 M, Figure 4D). This TRPV4-mediated osmodetection in saphenous nerve
result suggests that release of calcium from intracellular C-fibers. Thirteen single cutaneous C-fibers from the
stores increases [Ca2]i to a level that inhibits a subse- saphenous nerve were recorded in vivo. None of the
quent activation of TRPV4 by another stimulus. Thus, fibers showed spontaneous activity. Intradermal injec-
activation of TRPV4 in nociceptors appears to be tightly tion of hypotonic solution (5 l deionized water) elicited
regulated by [Ca2]i. activity in 7 of the 13 fibers (Figure 6A, upper trace).
The effect of hypotonic stimulus was brief, and after
approximately 25 s the fibers stopped firing. When PGE2TRPV4 Protein in Peripheral Nerve
To detect TRPV4 protein expression, we generated an (2.5 l, 100 ng) was intradermally injected prior to a
second hypotonic challenge, the number of action po-affinity-purified polyclonal anti-TRPV4 antibody using a
Neuron
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Figure 6. Primary Afferent Response to Hypotonic Stimulation Is Enhanced by PGE2
(A) Recording of cutaneous C-fibers from the saphenous nerve. The fiber did not have spontaneous activity. When challenged with an
intradermal injection of hypotonic solution (5 l deionized water), the fiber started firing a burst of action potentials (upper trace). Subsequent
intradermal injection of PGE2 (2.5 l, 100 ng) produced a low level of spontaneous activity (middle trace). A second hypotonic challenge
following the injection of PGE2 elicited a train of action potentials (bottom trace).
(B) Mean value  SEM of mechanical thresholds from hypotonic responsive (n  7) and nonresponsive C-fibers (n  6).
(C) Mean value  SEM of conduction velocities of the two groups of C-fibers.
(D) Mean value  SEM of the response of hypotonic sensitive C-fibers before and after intradermal injection of PGE2 (2.5 l, 100 ng), paired
Student’s t test, p  0.05.
tentials in C-fibers evoked by hypotonic solution was Hypotonic Stimulation of Sensitized Nociceptors
Is Noxious and Is Mediated by TRPV4significantly increased (Figure 6A, bottom trace). Neither
the mechanical threshold nor the conduction velocity We next investigated whether hypotonic stimulus could
induce nociceptive behavior in rat via the activation ofof the hypotonicity-responsive C-fibers was significantly
different from those of the nonresponsive C-fibers (Fig- TRPV4 channels. Injection of 10 l hypotonic (deionized
water) or isotonic solution (0.9% NaCl solution) in theures 6B and 6C). As shown in Figures 6A and 6D, intra-
dermal injection of PGE2 resulted in a significant in- hindpaw did not induce nociceptive behavior (Figure
7A). When PGE2 was administered prior to the injectioncrease in the mean number of action potentials evoked
by the hypotonic stimulus (27  7 before PGE2 versus of 10l hypotonic solution, significant flinching behavior
was observed during the 5 min period following the68  17 after PGE2, p  0.05, paired Student’s t test,
n  7). Furthermore, 2 of the hypotonicity-insensitive hypotonicity challenge (Figure 7A, mean  SEM, 8.8 
1.2 after PGE2 versus 0.2  0.2 before PGE2, p  0.05,C-fibers became sensitive after PGE2. Of note, only 3 of
the 7 hypotonicity-sensitive C-fibers showed a decrease paired Student’s t test, n  6). However, when PGE2
was administered 30 min prior to the injection of 10 lin their mechanical thresholds after application of PGE2.
Therefore, PGE2-induced sensitization of the response of isotonic solution, again no flinching behavior was
elicited (Figure 7A, mean  SEM, 1.2  0.7 after PGE2to hypotonic stimuli can occur independent of changes
in mechanical threshold. versus 0.0  0 before PGE2, p  0.05, paired Student’s
Osmosensing by DRG Neurons
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t test, n  6). Hindpaws in groups injected with isotonic
or hypotonic solution were similarly sensitized to me-
chanical stimulation by intradermal injection of PGE2
(data not shown, p  0.05, unpaired Student’s t test,
n  6).
To assess whether TRPV4 could be responsible for
the nociceptive behavior (flinches) elicited after sensiti-
zation of the C-fibers with PGE2, three groups of rats
were prepared. Rats were treated by spinal intrathecal
administration of either TRPV4 antisense, mismatch se-
quence, or saline (0.9% NaCl) solution for 3 days. There
were no statistically significant differences in the PGE2-
induced mechanical hyperalgesia among the three
groups of rats (data not shown, p  0.05, Tukey’s multi-
ple comparison test). As shown in Figure 7A, rats treated
with TRPV4 antisense showed a 50% decrease in the
number of flinches during the first 5 min following the
hypotonic injection (mean  SEM, 8.8  1.2 in control
versus 4.5  0.4 for the antisense-treated, p  0.05,
unpaired Student’s t test, n  10). Rats treated with
either saline or mismatch sequence did not show a sig-
nificant difference in the number of flinches induced by
hypotonicity when compared to control (mean  SEM,
9.3  0.7, n  8 for saline-treated; 8  0.5, n  13 for
mismatch-treated versus 8.8  1.2, n  6 for control,
p  0.05, Tukey’s multiple comparison test).
Recently, intact hot and touch sensation was ob-
served in TRPV4 knockout mice (Suzuki et al., 2003).
Thus, we tested change in mechanical threshold and
latency of the hindpaw to withdraw from a hot stimulus.
As shown in Figure 7B, there was no significant differ-
ence in the mechanical or thermal thresholds between
the antisense- and mismatch-treated rats. The thresh-
olds in both groups of treated animals did not signifi-
cantly differ from the control baseline measured (p 
0.05, Tukey’s multiple comparison test, n  6 for each
condition).
Western blot analysis showed a specific 41%  17%
diminution of TRPV4 protein expression level (p 0.017,
unpaired Student’s t test, n  8 for antisense-treated
and n 9 for mismatch-treated) in the saphenous nerve
in antisense-treated rats (Figure 7B). VR1 and tubulin
antibodies were used as a test of antisense specificity
and as a loading control, respectively. The level of ex-
pression of TRPV1 protein remained unchanged under
the TRPV4 antisense and mismatch treatment (p 0.05,
unpaired Student’s t test, n  6 for both groups). These
data suggest that TRPV4 is involved in the transductionFigure 7. Hypotonicity Is Noxious after Exposure to PGE2
of the hypotonic-induced nociceptive behavior elicited
(A) Mean  SEM of flinches induced by injection of an isotonic or
after sensitization with PGE2.hypotonic solution in the rat hindpaw. Injection of 10 l of isotonic
or hypotonic solution did not induce pain-related behavior. After
PGE2 sensitization of the hindpaws, injection of 10 l hypotonic
solution elicits a significant number of flinches, whereas isotonic (left panel, p  0.05, Tukey’s multiple comparison test, n  6) or in
solution did not. Rats treated with TRPV4 antisense showed a 50% the latencies to withdraw the hindpaw from a heat source (right
decrease in the number of hypotonic-induced flinches during the panel, p  0.05, Tukey’s multiple comparison test, n  6) between
first 5 min following the hypotonic injection (mean  SEM, 8.8  antisense- or mismatch-treated rats.
1.2 in control versus 4.5  0.4 for the antisense-treated, p  0.05 (C) Selective knockdown of TRPV4 protein expression in saphenous
unpaired Student’s t test, n  10). Rats treated with either saline or nerve. Top: the antisense-treated rats showed a 41%  17% de-
mismatch sequence did not show a significant difference in the crease in the level of TRPV4 protein compared to the mismatch-
number of flinches compared to control (p  0.05, unpaired Stu- treated rats (p 0.017, unpaired Student’s t test, n 8 for antisense
dent’s t test and Tukey’s multiple comparison test). Of note, there and n  9 for mismatch-treated rats). The amount of protein in both
were no significant differences in the PGE2-induced mechanical hy- lanes was confirmed to be comparable (16.8 g/lane) by reprobing
peralgesia among the three groups of rats (data not shown, p  with an -tubulin antibody. Bottom: TRPV1 protein level remained
0.05, Tukey’s multiple comparison test). unchanged in the TRPV4 antisense-treated rats (p  0.05, unpaired
(B) There was no significant difference in the mechanical thresholds Student’s t test, n  6).
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Figure 8. N-Terminal TRPV4 Splice Variant
(A) Nucleotide sequence alignment of the region corresponding to the amplified RT-PCR product with the primer pair TRPV4-1. The missing
nucleotide sequence from the 201 bp product is highlighted. Bold lines indicate the localization of the TRPV4-F2 primer.
(B) Schematic representation of the localization of the two pairs of TRPV4 primers on the rat TRPV4 gene. From a single cell responsive to
both a hypotonic stimulus and 4-PDD, a first round of PCR was performed using the forward primer of the primer pair TRPV4-1 (TRPV4-F1)
and the reverse primer of pair TRPV4-2 (TRPV4-R2). The second round of PCR was done using either the TRPV4-1 or TRPV4-2 primer pairs.
The TRPV4-1 primer pair yields the 201 bp and the 428 bp products. Enzymatic restriction was performed to verify the 428 bp PCR product;
the enzymes Afl II (yielding 173  255 bp products) and Sac I (yielding 334  94 bp products) were used. To verify the 298 bp PCR product
amplified with the TRPV4-2 primer pair, the enzymes Hinc II (yielding 136 bp  162 bp products) and Hinf I (yielding 187 bp  111 bp products)
were used. This neuron expresses both the potential splice variant and TRPV4 mRNAs.
(C) Autoradiograph of a rat multiple tissue premade membrane probed with a RNA probe corresponding to the 428 bp PCR product. Heart,
kidney, and liver show two bands of 2.8 and 3.2 Kb. Lung only shows the 2.8 Kb band, whereas spleen only shows the 3.2 Kb band. Skeletal
muscle and testis did not show any band.
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Detection of a N-Terminal Splice Variant of TRPV4 likely by tyrosine kinase phosphorylation (Strotmann et
al., 2000; Xu et al., 2003). It was shown recently that aAs shown in Figure 1C, in neurons responsive to the
30% hypotonic stimulus, we amplified by single-cell RT- subpopulation of capsaicin-sensitive trigeminal neurons
responded with variable magnitude to hypotonicity andPCR a 201 bp band with the TRPV4-1 primer pair. Enzy-
matic restriction performed with two different enzymes a nonselective cation channel was proposed to be in-
volved (Viana et al., 2001). TRPV4 mRNA is present in(Sac I and Sma I) ruled out the possibility of a nonspecific
PCR product (data not shown). The two PCR products trigeminal neurons (Liedtke et al., 2000) and is also de-
tected in dorsal root ganglia (Guler et al., 2002). Recent(the expected 428 bp and the 201 bp) were subcloned
into a pCR-II TOPO vector (Invitrogen Life Technologies) reports characterize TRPV4 as a polymodal receptor
activated by hypotonicity, heat, acid, and possibly byand DNA sequencing was performed. Sequence analy-
sis showed that the 201 bp product lacked a 227 bp an unidentified intracellular ligand (Nilius et al., 2003;
Suzuki et al., 2003). Based on these findings, we investi-portion of DNA (Figure 8A) corresponding to exon 4 and
the first 61 nucleotides of exon 5 (Figure 8B). A new pair gated the potential role of TRPV4 in hypo-osmotic de-
tection in nociceptive DRG neurons and the involvementof primers, identified as TRPV4-2, targeted to the splice
variant sequence by localization of the forward primer of osmodetection in peripheral pain mechanisms.
(denoted as TRPV4-F2) on the splice locus, was de-
signed (Figure 8B). DRG neurons were challenged with Mechanism for the Hypotonicity-Induced Calcium
a 30% hypotonic solution and subsequently with an Increase in Nociceptors
isotonic solution containing 4-PDD (10M). Cytoplasm We show the existence of a mechanism for transduction
from neurons responsive to both stimuli in calcium im- of hypotonic stimulation in a subpopulation of small- to
aging was harvested and single-cell RT-PCR was per- medium-diameter nociceptors. The mechanisms in-
formed. Enzymatic restriction analysis was performed volved in the hypotonicity-induced increase in [Ca2]i
for all the cells expressing TRPV4 mRNA. The enzymes can be grouped into two categories (Lang et al., 1998):
Afl II, yielding 173 bp and 255 bp products, and Sac I, activation of calcium influx and/or release of calcium
yielding 334 bp and 94 bp products, were used to verify from intracellular stores. Our data with Ca2-free solu-
that the 428 bp band amplified with the TRPV4-1 primer tions show that entry of extracellular calcium is essential
pair was specific. The enzymes Hinc II, yielding 136 bp for the hypotonic-induced increase in [Ca2]i in DRG
and 162 bp products, and Hinf I, yielding 187 bp and nociceptors. However, the hypotonicity-induced [Ca2]i
111 bp products, were used to verify that the 298 bp increase is smaller in the presence of calcium store
band amplified with the TRPV4-2 primer pair was also blockers. Most of the blocking effects seemed due to
specific (Figure 8B). For three different responsive neu- SKF 96365, which was shown to block members of the
rons, the PCR product amplified with TRPV4-2 primers TRPC subfamily of TRP channels (Okada et al., 1998;
was subcloned into a pCR-II TOPO vector. Sequence Zhu et al., 1998; Inoue et al., 2001). Thus, we cannot
analysis confirmed 100% homology with the expected exclude the possibility of a direct interaction of that
“spliced” sequence. Our preliminary results in single- drug with TRPV4 channels; we suggest that the TRPV4-
cell RT-PCR did not show a differential distribution of mediated extracellular influx of Ca2 may trigger the
the two TRPV4 mRNAs 15 of 16 neurons that were re- release of Ca2 from intracellular stores as it was shown
sponsive to hypotonic stimulation expressed both for TRPV1 and capsaicin (Eun et al., 2001).
mRNAs. Supporting that idea, we also show that, in nocicep-
To confirm our findings, Northern blot experiments tors, 4-PDD is unable to potentiate the hypotonicity-
were performed using the 428 bp PCR product se- induced [Ca2]i increase unless the intracellular stores
quence as a probe. In RNA from DRG, we observed a were blocked and depleted. TRPV4 appears to be tightly
3.2 Kb band and another faint band at approximately regulated by intracellular and extracellular calcium level
2.8 Kb (data not shown). Therefore, in order to confirm in nociceptors, which is in agreement with other reports
the existence of a second band, we performed Northern (Strotmann et al., 2003; Watanabe et al., 2003). This
blot experiments with our probe on tissue known to finding is significant because in some neuropathies, such
express higher levels of TRPV4. In heart, kidney, and as diabetic peripheral neuropathy, alteration in neuronal
liver, we detected two transcripts of 2.8 and 3.2 Kb, mechanisms are linked to changes in intracellular signal-
as previously shown (Strotmann et al., 2000); lung only ing systems that can influence [Ca2]i levels such as
shows the 2.8 Kb band, whereas spleen only shows the mitochondrial dysfunction (Srinivasan et al., 2000). It has
3.2 Kb band (Figure 8C). The Northern blot analysis and also been shown that impaired mitochondrial function
single-cell RT-PCR experiments support the existence leads to opening of TRP channels (Agam et al., 2000).
of a TRPV4 splice variant.
A TRPV4 N-Terminal Splice Variant?
Our results in single-cell RT-PCR and Northern blot anal-Discussion
ysis are preliminary but support the existence of a
TRPV4 N-terminal splice variant in rat. Although the en-Exposure to hypotonic extracellular solution induces
cell swelling due to the osmotic entry of water into the tire sequence of the detected splice variant has not yet
been determined, we can infer that the splice occurs incell. Because swelling induces membrane stretch, previ-
ous studies testing the effect of hypotonic stimuli on the region of amino acids 184–260. The splice variant
likely lacks one ankyrin repeat, which would potentiallysensory cells (Harada et al., 1994) focused on the poten-
tial implication of stretch-activated channels in the re- influence its interaction with the cytoskeleton or the
interaction between its potential constitutive subunits.sponse. TRPV4 is not activated by stretch but more
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Other investigators have shown that the amino-terminal also been shown that hyperosmolarity elicits substance
P release from rat C-fibers (Garland et al., 1995). Andomain of TRPV4 is key for its response to tonicity and
heat (Liedtke et al., 2000; Watanabe et al., 2002b) and is extended literature is available on hyperosmolarity and
neuropathies probably because of the importance ofthe site of tonicity-dependent tyrosine phosphorylation
(Xu et al., 2003). Further experiments are needed to diabetes usually characterized by hyperglycemia. How-
ever, the existence of hypoglycemic neuropathies (Moh-determine the full sequence of this potential splice vari-
ant and to distinguish its function. seni, 2001) and the fact that in diabetic ketoacidosis
some patients have hypo-osmolar plasma suggest the
possible importance of hypo-osmolarity in neuropa-Hypotonicity Excites Nociceptive Neurons
thies. In addition, the fact that DRG lack a blood-nerveOur finding brings a new perspective to the physiological
barrier supports the idea of their possible role as sensorrole of TRPV4. Our electrophysiological experiments in
of our body’s internal osmotic milieu.vitro and in vivo are consistent, extracellular hypotonic-
Little information is yet available concerning the con-ity excites a subset of nociceptors, and we provide evi-
sequences of fluctuations of extracellular osmolarity indence implicating TRPV4 channels in this pathway.
the periphery during inflammatory states or in neuropa-Prostanoids such as PGE2 are generated by most cells
thies. Our results suggest that TRPV4 is a transducer ofin response to mechanical, thermal, or chemical injury
osmotic stimulation and, more specifically, a transduceror during inflammation. PGE2 acts on EP prostanoid
involved in inflammatory pain. These findings representreceptors, present on sensory neurons, and stimulates
critical developments in the delineation of TRPV4 func-adenylyl cyclase and/or PLC activity. The most promi-
tion, but tantalizing questions remain. Is TRPV4 involvednent cellular signaling pathway in which TRP channels
in inflammatory states following injuries? Does dysfunc-play a role are mediated via phospholipase C (PLC)
tion of TRPV4 play a role in neuropathies? What is the(Minke and Cook, 2002). These findings led us to the
relevance of the splice variant? Answers to these ques-hypothesis that PGE2 may enhance the effect of a hypo-
tions may indicate that TRPV4 is a potential pharmaco-tonic stimulus on nociceptors. Thus, hypotonicity be-
logical target for the development of novel analgesicscame noxious to the animal when nociceptive fibers
in inflammatory pain.were sensitized by PGE2.
Our results with the TRPV4 antisense-treated rats are
Experimental Proceduresin agreement with the findings that in TRPV4 knockout
mice, mechanical and thermal thresholds are un- DRG Cell Culture
changed (Suzuki et al., 2003). However, they state that L2-L6 dorsal root ganglion (DRG) were harvested from adult rat and
hypotonicity is the less sensitive stimulus for TRPV4. dissociated as described previously (Reichling and Levine, 1997).
Cells were maintained in Dulbecco’s modified Eagle’s (MEM) me-Suzuki et al. drew their conclusions after testing hypoto-
dium supplemented with 50–100 ng/ml NGF, 100 units/ml penicillin/nicity on transfected cells that do not always express
streptomycin, MEM vitamins, and 10% heat-inactivated Fetal CalfTRPV4 at the membrane but rather in intracellular local-
Serum. The components of the culture media were purchased from
ization (Guler et al., 2002), and they did not test any Invitrogen Life Technologies. Dissociated cells were plated on cover
pain-related behavior after a hypotonic challenge. We slips treated with poly-DL-ornithine (0.1 mg/ml; Sigma) and laminin
show here that hypotonicity excites TRPV4 in vitro and (5 g/ml; Invitrogen Life Technologies) and incubated at 37C in
96.5% air, 3.5% CO2.in vivo and that in sensitized states (such as inflamma-
tion, for example), hypotonicity becomes even a more
Recording Solutions for Electrophysiologyefficient stimulus and is able to be noxious in the animal.
or Calcium ImagingThat finding is of primary interest because it is the first
Extracellular solutions (Table 1) were made fresh, and pH (7.38) and
demonstration that TRPV4, or any osmosensitive chan- osmolarity were measured before each experiment.
nel, is involved in pain transduction in sensory neurons. All drugs or blockers tested were diluted daily from stock solutions
in dimethylsulfoxide (DMSO). Capsaicin, SKF 96365, thapsigargin,Elucidation of a relationship between osmolarity and
cyclopiazonic acid (CPA), lanthanum, and 4-PDD were purchasedneuronal excitability is of considerable clinical impact.
from Sigma and ruthenium red from Research Biochemicals Interna-Disturbances of osmolarity or cell volume is common
tional (RBI).to different types of disease such as diabetes (Puliyel
and Bhambhani, 2003), alcoholism (Vamvakas et al., In Vitro Electrophysiological Recordings
1998), schizophrenia (Canuso and Goldman, 1999), and DRG neurons were recorded in whole-cell current-clamp mode be-
asthma (Fujimura et al., 1998). Studies on the gastroin- tween 24 and 72 hr after dissociation. Experiments were carried
out at 20C–23C with an Axoclamp 200 A patch amplifier (Axontestinal tract show that hypotonic solutions increase the
Instruments). Patch clamp electrodes had a resistance of 3–4 M	activity of sensory vagal neurons (Mei and Garnier, 1986;
and were filled with the following intracellular solution: 140 mM KCl,Kobashi and Adachi, 1996). In the periphery, water is
2 mM NaCl, 3 mM MgCl2, 10 mM HEPES, and 5 mM EGTA (pH 7.3)known to be an irritant and there are many examples of with KOH (290 mOsm). The volume of the chamber was 200 l
diseases or painful conditions such as “tropical immer- and the extracellular solutions were perfused with a ValveBank 8
sion foot” in which patient’s feet are painful following a perfusion system (Automate Scientific) at a flow rate of 1–2 ml/min.
Data were sampled (10 kHz) and filtered (2 kHz) with pClamp 8prolonged immersion in water (Tsai and Maibach, 1999).
(Axon Instruments) and analyzed with Origin software (OriginLab).Nociception-related neuropeptides including substance
P are suspected to mediate the intense itching in the
Single-Cell RT-PCRaquagenic pruritus, which develops after contact with
Single-cell RT-PCR experiments were conducted as described pre-
water in the absence of cutaneous signs (Lotti et al., viously (Alessandri-Haber et al., 2002). Briefly, at the end of re-
1994); and in aquadynia, a water-related pain syndrome, cordings, cytoplasm was harvested and reverse transcription was
immediately performed using Superscript II (Invitrogen). Two suc-VIP release may be involved (Misery et al., 2003). It has
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Table 1. Composition of Extracellular Solutions
Osmolarity NaCl KCl KH2PO4 MgSO4 MgCl2 CaCl2 NaHCO3 D-mannitol HEPES
(mOsm) (mM) (mM) (mM) (mM) (mM) (mM) (mM) (mM) (mM)
Isotonic 312 124 5 1.2 0 1.3 2.4 26 0 0
Isotonic Ca0 314 76 5 1.2 1.3 2.4 0 26 100 0
Hypotonic 30% 219 74 5 1.2 0 1.3 2.4 26 0 0
Hypotonic 30% Ca0 212 76 5 1.2 1.3 2.4 0 26 0 0
Isotonica 312 88 5 0 0 1 2.4 0 110 10
Hypotonic 15%a 260 88 5 0 0 1 2.4 0 50 10
Hypotonic 30%a 219 88 5 0 0 1 2.4 0 10 10
Hypotonic 30% Ca0a 219 88 5 0 0 3.4 0 0 10 10
Data is of solutions used for electrophysiology experiments
a Solutions used for calcium imaging experiments
cessive PCR amplifications (initial Taq activation step at 94C for were split 48 hr after transfection and selected with 800g/ml genet-
icin (Invitrogen); discrete colonies were isolated with cloning rings.15 min, then 94C for 30 s, 60C for 1 min, 72C for 1 min, and 72C
for 7 min) were performed for 28 and 38 cycles using HotstarTM Taq CHO-K1 cells stably transfected with TRPV4 (CHO-TRPV4) were
kindly provided by Drs. J. Friedman and W. Liedtke (Rockefeller(Qiagen). Two different primers pairs were used for TRPV4 (acces-
sion number AF263521): TRPV4-1 (nucleotides 523–950) and University, NY). CHO-MOCK and CHO-TRPV4 cell lines were cul-
tured in F12 Ham’s medium supplemented with 10% Fetal BovineTRPV4-2 (nucleotides 631–928). The housekeeping gene GAPDH
(accession number AF 106860, nucleotides 320–556) was used as Serum, 200 mM glutamine, 100 mcg/ml streptomycin/100 units/ml
penicillin G, and 250 g/ml geneticin (Invitrogen). Cells were plateda positive control. Gels were analyzed with AlphaEaseFCTM software
(Alpha Innotech Corporation). on cover slips 48 hr before calcium imaging experiments.
Northern BlotIn Vivo Single-Fiber Electrophysiology
Rats were anesthetized with sodium pentobarbital (initially 50 mg/ Northern blot experiments were performed using a rat Multiple Tis-
sue Northern blot premade membrane (rat MTN blot, Clontech). Thekg, i.p.), with additional doses given throughout the experiment to
maintain areflexia. Single cutaneous C-fibers from the saphenous 428 bp PCR product was used as the probe after ligation to the T7
polymerase promoter (Lig’nScribe, Ambion) and transcription withnerve were recorded as described previously (Chen and Levine,
1999). Fibers with conduction velocities less than 2 m/s were classi- the RNA StripEZ kit (Ambion). The antisense RNA probe was then
purified with the RNaid kit (Bio 101, Inc). In parallel, 5 g of ratfied as C-fibers (Willis, 1985). The action potential corresponding to
the C-fiber whose receptive field had been identified was deter- poly(A) RNA was extracted from DRG, separated by electrophore-
sis on a 1% denaturant agarose gel, and transferred to a Bright Starmined by the latency delay technique (Handwerker et al., 1991).
Mechanical threshold was determined with calibrated von Frey hairs membrane. Hybridization was carried out using the Northern Max
kit (Ambion).(Ainsworth) and defined as the lowest force that elicited two or more
spikes within 1 s, in at least 6 of 10 trials. Hypotonic solution (5.0 l,
deionized water) and PGE2 (2.5 l, 100 ng, Sigma) were intradermally Antibody Generation and Purification
injected 1 mm from the center of a fiber’s mechanical receptive A synthetic peptide (CDGHQQGYAPKWRAEDAPL) corresponding
field. to the C terminus of the rat TRPV4 was synthesized and conjugated
to keyhole limpet hemocyanin (KLH) via its N terminus by Invitrogen
Life Technologies. Rabbits were immunized with the KLH-conju-Measurement of Intracellular Ca2 Concentration
DRG neurons were recorded between 24 and 72 hr after dissocia- gated peptide (240 g peptide for the first immunization and 120
g thereafter) according to standard procedures at Lampire Biologi-tion. Neurons were loaded with 5 M fura-2 acetoxymethyl ester
(fura-2 AM; Molecular Probes) for 20 min in isotonic solution (312 cals. The resulting immune serum was purified using affinity chroma-
tography made from the synthetic peptide and Sulfolink couplingmOsm). The volume of the chamber was 300 l and the perfusion
was carried out at 20C–23C at a flow rate of 1–2 ml/min. Cells gel (Pierce Biotechnology). Purification was performed by incubat-
ing 1 ml of antiserum/ml of affinity resin for 2 hr at room temperaturewere perfused with isotonic solution for 10 min before the beginning
of the recording to allow hydrolysis of the fura-2 AM. with constant rotation followed by washing with 20 bed volumes of
binding buffer (100 mM sodium borate and 0.02% sodium azideThe measurement of [Ca2]i was performed by digital ratiometric
imaging of fura-2 AM with an intensified charge-coupled device [pH 8.0]). The purified antibody was eluted with 10 bed volumes of
ImmunoPure Gentle Ag/Ab elution buffer (Pierce Biotechnology).camera ICCD (Stanford Photonics, Inc). Fluorescence was excited
at 340 and 380 nm and the emitted light was long filtered at 520
nm. The fluorescence ratio, F340/F380, was calculated and acquired Western Blot
with METAFLUOR imaging system software (Universal Imaging Saphenous nerves from anesthetized rats (178–198 g male Sprague-
Corporation). The vehicle for the fura-2 AM, DMSO, was tested Dawley rats) were ligated with silk surgical suture (4-0) 1 cm above
separately on DRG neurons to verify that it did not induce any the knee-level bifurcation of the nerves. A 5 mm section of saphe-
response. nous nerve proximal to the ligation was removed 3 days after the
In absence of specific blockers of TRPV4 and given the ionic surgery. Protein membrane preparation and Western blot analysis
complexity of DRG neurons, experiments were performed in condi- were performed as previously described (Parada et al., 2003). The
tions that were less likely to activate other ions channels: low NaCl membrane was probed with affinity-purified anti-TRPV4 antibody
concentration, HEPES buffer, room temperature, and where only (1:750) followed by incubation with horseradish peroxidase-conju-
the amount of mannitol was modified to change the solutions osmo- gated (HRP) goat anti-rabbit IgG (1:10,000 Santa Cruz biotechnol-
larity but in which the activation of TRPV4 may not be maximal. ogy). Membranes were incubated with enhanced chemilumines-
cence reagents (Pierce Biotechnology) and exposed to films. To
determine the specificity of the TRPV4 antisense probe and to nor-CHO-K1 Transfection and Cell Culture
Negative control cell line (CHO-MOCK) was generated by transfect- malize the loaded samples, affinity-purified goat polyclonal TRPV1
antibody (1:500, Santa Cruz biotechnology) and -tubulin (1:2000,ing CHO-K1 cells (ATCC, Manassas) with 10 g pcDNA3.1 plasmid
DNA (Invitrogen Life Technologies) per 10 cm dish using a standard Sigma) were used to reprobe the membrane. Respectively, a HRP-
conjugated rabbit anti-goat IgG (1:4000, Santa Cruz biotechnology)calcium phosphate/HEPES protocol (Sambrook et al., 1989). Cells
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or HRP-conjugated goat anti-mouse IgG (1:10,000, Sigma) were Alessandri-Haber, N., Alcaraz, G., Deleuze, C., Jullien, F., Manrique,
C., Couraud, F., Crest, M., and Giraud, P. (2002). Molecular determi-used as the secondary antibodies.
nants of emerging excitability in rat embryonic motoneurons. J.
Physiol. 541, 25–39.Oligodeoxynucleotides
Oligodeoxynucleotides (ODNs) were synthesized by Invitrogen Life Aley, K.O., Martin, A., McMahon, T., Mok, J., Levine, J.D., and Mess-
Technologies. The antisense ODNs sequence 5
-CATCACCAGGAT ing, R.O. (2001). Nociceptor sensitization by extracellular signal-
CTGCCATACTG-3
 was directed against a unique region of the rat regulated kinases. J. Neurosci. 21, 6933–6939.
TRPV4 channel. The mismatch ODN sequence was designed by Canuso, C.M., and Goldman, M.B. (1999). Clozapine restores water
mismatching 7 bases (denoted by bold face) of the TRPV4 antisense balance in schizophrenic patients with polydipsia-hyponatremia
sequence, 5
-CAACAGGAGGTTCAGGCAAACTG-3
. ODNs were re- syndrome. J. Neuropsychiatry Clin. Neurosci. 11, 86–90.
constituted in nuclease-free 0.9% NaCl (10 g/l, LabChem) and
Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, T.A., Le-were intrathecally administrated once daily at a dose of 40 g for
vine, J.D., and Julius, D. (1997). The capsaicin receptor: a heat-3 days.
activated ion channel in the pain pathway. Nature 389, 816–824.
Caterina, M.J., Rosen, T.A., Tominaga, M., Brake, A.J., and Julius,Nociceptive Behavior
D. (1999). A capsaicin-receptor homologue with a high threshold forBehavioral experiments were performed on 220–250 g male
noxious heat. Nature 398, 436–441.Sprague-Dawley rats (Charles River). Experimental protocols were
Chen, X., and Levine, J.D. (1999). NOS inhibitor antagonism of PGE2-approved by the UCSF Committee on Animal Research and con-
induced mechanical sensitization of cutaneous C-fiber nociceptorsformed to NIH guidelines for use of animals in research.
in the rat. J. Neurophysiol. 81, 963–966.Intrathecal ODNs Treatment
Intrathecal ODNs treatment was as described in Papir-Kricheli et Delany, N.S., Hurle, M., Facer, P., Alnadaf, T., Plumpton, C., King-
al. (1987). Rats were anesthetized with 2.5% isoflurane inhalation horn, I., See, C.G., Costigan, M., Anand, P., Woolf, C.J., et al. (2001).
anesthetic (97.5% O2), a 30-gauge needle was inserted into the Identification and characterization of a novel human vanilloid recep-
subarachnoid space on the midline between the L4 and L5 verte- tor-like protein, VRL-2. Physiol. Genomics 4, 165–174.
brae, and 20 l of ODNs was injected at 1 l/s, using a 3/10 cc BD Eun, S.Y., Jung, S.J., Park, Y.K., Kwak, J., Kim, S.J., and Kim, J.
micro-syringe. (2001). Effects of capsaicin on Ca2 release from the intracellular
Flinching Test Ca 2 stores in the dorsal root ganglion cells of adult rats. Biochem.
Flinching tests were as described in Taylor et al. (1995). Flinch tests Biophys. Res. Commun. 285, 1114–1120.
were run on the 4th day following initiation of the ODNs treatment (10
Fujimura, M., Amemiya, T., Myou, S., Ishiura, Y., Sasaki, S., andhr postinjection). Animals were placed in an open acrylic observation
Matsuda, T. (1998). A partial involvement of histamine in ultrasoni-chamber for 30 min to accommodate them to their surroundings.
cally nebulized distilled water-induced bronchoconstriction inRats were removed and restrained while 10 l hypotonic (deionized
guinea-pigs. Br. J. Pharmacol. 125, 902–908.water) or isotonic solution (0.9% NaCl solution) was intradermally
Garland, A., Jordan, J.E., Necheles, J., Alger, L.E., Scully, M.M.,administered into the dorsum of the hindpaw using a 30-gauge
Miller, R.J., Ray, D.W., White, S.R., and Solway, J. (1995). Hyperto-needle connected with a 100 l Hamilton syringe by polyethylene
nicity, but not hypothermia, elicits substance P release from rattubing. Rats were observed immediately after the injection for a
C-fiber neurons in primary culture. J. Clin. Invest. 95, 2359–2366.5 min period.
Mechanical Thresholds Gorke, K., and Pierau, F.K. (1980). Spike potentials and membrane
Mechanical thresholds in rat were evaluated by the Randall-Sellito properties of dorsal root ganglion cells in pigeons. Pflugers Arch.
paw-withdrawal flexion-reflex test (Aley et al., 2001) with an Ugo- 386, 21–28.
Basile analgesymeter (Stoelting). Baseline mechanical thresholds Guler, A.D., Lee, H., Iida, T., Shimizu, I., Tominaga, M., and Caterina,
were determined before and after PGE2 treatment as the mean of M. (2002). Heat-evoked activation of the ion channel, TRPV4. J.
two measurements performed 5 min apart. PGE2 was administered Neurosci. 22, 6408–6414.
intradermally 30 min prior to the hypotonic or isotonic test in the
Handwerker, H.O., Kilo, S., and Reeh, P.W. (1991). Unresponsivesame site of injection. PGE2-induced hypersensitivity was quantified afferent nerve fibres in the sural nerve of the rat. J. Physiol. 435,as the change in mechanical nociceptive threshold.
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